The CMS fails to check hospitals’ pricing data for accuracy and completeness, raising questions about whether the data can be used as intended to help payers and patients shop for services, according ...

In a brief commentary, LiveData CEO Jeff Robbins explains the importance of modernizing healthcare and the impact of generative AI, interoperability, and advanced operational systems on healthcare ...

The litigation comes as pharmacy benefit managers Express Scripts, CVS Caremark and Optum Rx have faced growing criticism over their role in high drug costs — including a recent lawsuit from the ...

A handful of plans owned by the nation's largest MA payer are the latest to ask the court to help raise their valuable quality scores.

These leadership changes come as Ada continues to expand its global reach and enterprise partnerships. With availability in nearly 150 countries and 11 languages, Ada now serves over 13 million users ...

Prenuvo, the pioneer in proactive whole-body screening for early detection of cancer and other diseases, today announced the opening of the first clinic in Scottsdale, Arizona. This new location, ...

Only 25% of Humana members will be in plans with four stars or above next year, down from 94% this year, the insurer disclosed Wednesday. The downgrade could wipe out Humana’s profits in 2026.

A bipartisan group of two dozen representatives pushed officials to preserve the pandemic-era prescribing changes for buprenorphine, arguing telehealth increases access and prevents overdoses.

Rezilient Heath, a leading tech-enabled healthcare company, has announced today that it has closed a $10M Series A funding round led by Govo Venture Partners with participation from Bridge Ventures, ...

Mission Hospital’s emergency department is at double capacity as supply shortages create processing delays, nurses told Healthcare Dive.

Mike Waters’ resignation comes after other leadership changes at the telehealth vendor, including the departure of Teladoc’s former CEO this spring.

The agency will offer earlier meetings with drugmakers as well as solicit more patient feedback on the process.